How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells (2022)
Attributed to:
Development of enhanced gene specific technology for the isolation of proteins binding at a single locus in vivo.
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/ijms23179880
PubMed Identifier: 36077278
Publication URI: http://europepmc.org/abstract/MED/36077278
Type: Journal Article/Review
Parent Publication: International Journal of Molecular Sciences
Issue: 17
ISSN: 1422-0067